PT - JOURNAL ARTICLE AU - Foo, Cheryl Y. S. AU - Potter, Kevin AU - Nielsen, Lindsay AU - Rohila, Aarushi AU - Maravic, Melissa Culhane AU - Schnitzer, Kristina AU - Pachas, Gladys N. AU - Levy, Douglas E. AU - Reyering, Sally AU - Thorndike, Anne N. AU - Cather, Corinne AU - Evins, A. Eden TI - Implementation of Community Health Worker Support for Tobacco Cessation: A Mixed-Methods Study AID - 10.1101/2024.01.26.24301835 DP - 2024 Jan 01 TA - medRxiv PG - 2024.01.26.24301835 4099 - http://medrxiv.org/content/early/2024/04/17/2024.01.26.24301835.short 4100 - http://medrxiv.org/content/early/2024/04/17/2024.01.26.24301835.full AB - Objective Adults with serious mental illness have high tobacco use disorder rates and underutilization of first-line tobacco cessation pharmacotherapy. In a randomized trial, participants offered community health worker (CHW) support and primary care provider (PCP) education had higher tobacco abstinence rates at two years, partly through increased tobacco cessation pharmacotherapy initiation. This study determined the association between participant-CHW engagement and tobacco abstinence outcomes.Methods This was a secondary, mixed-methods analysis of 196 participants in the trial’s intervention arm. Effects of CHW visit number and duration, CHW co-led smoking cessation group sessions attended, and CHW-attended PCP visit number on tobacco use disorder pharmacotherapy initiation and tobacco abstinence were modeled using logistic regression. Interviews with 12 CHWs, 16 participants, and 17 PCPs were analyzed thematically.Results Year-two tobacco abstinence was associated with CHW visit number (OR=1.85, 95% CI=[1.29, 2.66]) and duration (OR=1.85, 95% CI=[1.33, 2.58]) and number of groups attended (OR=1.51, 95% CI=[1.00, 2.28]); effects on pharmacotherapy initiation were similar. 1-3 CHW visits per month over two years was optimal for achieving abstinence. Interviews identified engagement facilitators, including CHWs establishing trust, providing goal accountability, skills reinforcement, and assistance overcoming barriers to treatment access and adherence related to social determinants of health and illness factors. Robust training and supervision facilitated CHW effectiveness. Barriers included PCPs’ and care teams’ limited understanding of the CHW role.Conclusions Feasible CHW engagement was associated with tobacco abstinence in adults with serious mental illness. CHW implementation may benefit from promoting CHW training and integration within clinical teams.HighlightsGreater participant engagement with community health workers (CHWs) (e.g., visit number, duration) was associated with higher tobacco abstinence rates in a two-year intervention for adults with serious mental illness and tobacco use disorder.Interviews with participants, CHWs, and primary care providers (PCPs) indicated that CHWs built trust, facilitated health behavior change, helped participants overcome adverse social determinants of health and other barriers to obtaining effective tobacco use disorder treatment.Training and supervision were perceived to be essential to CHW effectiveness; CHWs and PCPs suggested insufficient integration of CHWs into psychiatric rehabilitation and healthcare teams as an addressable implementation barrier.Competing Interest StatementDr. Evins has served as a consultant to Charles River Analytics (NIDA SBIR grant). Dr. Cather has served as a consultant to Charles River Analytics (NIDA SBIR grant). Other investigators report no potential conflicts.Funding StatementThis work was funded by the Patient Centered Outcomes Research Institute (PCORI) Large Pragmatic Trial, 1504-30472; Integrated Smoking Cessation Treatment for Smokers with Serious Mental Illnesses (PI: Evins; co-PI; Reyering); ClinicalTrials.gov identifier, NCT02845440. Dr. Foo and Cather were supported by funding from the Massachusetts Department of Mental Health to the Massachusetts General Hospital Center of Excellence for Psychosocial and Systemic Research. Dr. Thorndike was supported in part by NIH grant K24 HL163073. Dr. Evins was supported in part by NIH grant K24 DA030443 and PCORI 1504-30472.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Mass General Brigham and Massachusetts Department of Mental Health institutional review boards gave ethical approval for this study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe complete de-identified dataset containing individual-participant level data that underpin the results reported in this article, together with the full study protocol, statistical analysis plan and statistical code used to generate the results will be archived, searchable, and open access, posted through the PCORI Patient-Centered Outcomes Data Repository, hosted by the University of Michigan's Inter-University Consortium for Political and Social Research (ICPSR. ICPSR is an open access repository that connects researchers to data funded by PCORI. According to PCORI's policy, the data requestor will enter a DUA and submit a request outlining their research purpose directly with the data repository. Their qualifications, research justification, data security plan, and assurance that the research will result in a generalizable, patient-relevant contribution will all be taken into account by a PCORI-designated review committee. Such requests and derived results are posted publicly. The DUA prohibits reidentification.